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Abstract
Ataxia telangiectasia mutated kinase (ATM) is a cell cycle checkpoint protein activated in response to DNA damage.
We recently reported that ATM plays a protective role in myocardial remodeling following β-adrenergic receptor
stimulation. Here we investigated the role of ATM in cardiac remodeling using myocardial infarction (MI) as a model.
Methods and Results: Left ventricular (LV) structure, function, apoptosis, fibrosis, and protein levels of apoptosis-
and fibrosis-related proteins were examined in wild-type (WT) and ATM heterozygous knockout (hKO) mice 7 days
post-MI. Infarct sizes were similar in both MI groups. However, infarct thickness was higher in hKO-MI group. Two
dimensional M-mode echocardiography revealed decreased percent fractional shortening (%FS) and ejection fraction
(EF) in both MI groups when compared to their respective sham groups. However, the decrease in %FS and EF was
significantly greater in WT-MI vs hKO-MI. LV end systolic and diastolic diameters were greater in WT-MI vs hKO-MI.
Fibrosis, apoptosis, and α-smooth muscle actin staining was significantly higher in hKO-MI vs WT-MI. MMP-2 protein
levels and activity were increased to a similar extent in the infarct regions of both groups. MMP-9 protein levels were
increased in the non-infarct region of WT-MI vs WT-sham. MMP-9 protein levels and activity were significantly lower
in the infarct region of WT vs hKO. TIMP-2 protein levels similarly increased in both MI groups, whereas TIMP-4
protein levels were significantly lower in the infarct region of hKO group. Phosphorylation of p53 protein was higher,
while protein levels of manganese superoxide dismutase were significantly lower in the infarct region of hKO vs WT.
In vitro, inhibition of ATM using KU-55933 increased oxidative stress and apoptosis in cardiac myocytes.
Citation: Foster CR, Daniel LL, Daniels CR, Dalal S, Singh M, et al. (2013) Deficiency of Ataxia Telangiectasia Mutated Kinase Modulates Cardiac
Remodeling Following Myocardial Infarction: Involvement in Fibrosis and Apoptosis. PLoS ONE 8(12): e83513. doi:10.1371/journal.pone.0083513
Editor: Alain-Pierre Gadeau, INSERM, France
Received August 6, 2013; Accepted November 5, 2013; Published December 16, 2013
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by
anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: This work is supported by National Institutes of Health (Grant numbers R21HL-091405 and R21HL-092459), a Merit Review award (number
BX000640) from the Biomedical Laboratory Research and Development Service of the VA Office of Research and Development, and institutional Research
and Improvement funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
* E-mail: singhk@etsu.edu
Introduction
Myocardial infarction (MI) induces a series of molecular and
structural changes in the left ventricle leading to a progressive
decline in LV performance [1–3]. The limited capacity for
regeneration of myocytes in the adult heart suggests that
cardiac myocyte loss due to apoptosis may contribute to the
progression of heart failure. Dynamic synthesis and breakdown
of extracellular matrix also plays a significant role in myocardial
remodeling post-MI [4,5]. Therefore elucidation of events
involved in the repair of the heart is an important clinical
determinant of survival post-MI [6].
Ataxia telangiectasia mutated kinase (ATM) is a
multifunctional kinase that affects multiple downstream targets
in response to cellular stress or damage. Mutation or deficiency
of ATM causes a hereditary multi-systemic disease called
Ataxia telangiectasia (A-T). Individuals with mutations in both
copies of the ATM gene suffer from increased susceptibility to
ionizing radiation, predisposition to cancer, insulin resistance,
immune deficiency, and premature aging. Carriers of one
mutated allele at the A-T locus make up ~1.4 to 2% of the
general population. These individuals with an ATM mutation in
one allele are spared from most of the symptoms of A-T, but
are more susceptible to cancer and ischemic heart disease
[7–9].
Previously, a search to identify novel apoptosis-related
genes using Super-Array technique followed by RT-PCR
analyses revealed that β-adrenergic receptor (β-AR)
stimulation increases expression of ATM in the heart and in
adult cardiac myocytes [10]. Using ATM heterozygous
knockout (hKO) mice and chronic β-AR stimulation as a model
of myocardial remodeling, we provided evidence that ATM
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plays an important role in β-AR-stimulated myocardial
remodeling with effects on ventricular function, apoptosis and
fibrosis [10]. Recently, using ATM-/- mice, we have shown that
lack of ATM induces structural and functional changes in the
heart with enhanced myocardial fibrosis and myocyte
hypertrophy. β-AR-stimulated apoptosis in WT hearts
associated with p53- and JNKs-dependent mechanism, while
decreased Akt activity may play a role in increased myocyte
apoptosis in the absence of ATM [11]. The objective of this
study was to investigate the role of ATM in myocardial
remodeling 7 days post-MI. The data presented here show that
deficiency of ATM affects heart function, infarct thickness,




Age-matched (~ 4 months old) male and female ATM
deficient mice were used as previously described [10].
Heterozygous knockout (hKO) and wild type (WT) ATM mice,
purchased from the Jackson Laboratory, were of 129xblack
Swiss hybrid background. Genotyping was performed by
polymerase chain reaction (PCR) using primers suggested by
the Jackson Laboratory. The absence of both ATM alleles
produces a lethal phenotype at ~2 months of age mainly due to
thymic lymphomas [12,13].
Ethics statement
The investigation conforms to the Guide for the Care and
Use of Laboratory Animals published by the US National
Institutes of Health (NIH Publication No. 85-23, revised 1996).
All of the experiments were performed in accordance with the
protocols approved by the East Tennessee State University
Animal Care and Use Committee.
Myocardial infarction
MI and measurements were performed as previously
described [14–16]. The left anterior descending coronary artery
was occluded using a 7-0 mm silk suture. Sham animals
underwent the same surgery without ligation of the coronary
artery.
Echocardiography
Transthoracic two-dimensional M-mode echocardiography
was performed as previously described [10,11]. All
echocardiographic assessments and measurements were
performed by the same investigator. A second person also
performed measurements on a separate occasion using the
same recordings with no significant differences in interobserver
variability.
Morphometric analyses
Following MI, hearts were removed and arrested in diastole
using KCl (30 mmol/L) followed by perfusion fixation with 10%
buffered formalin. Infarct size was measured using Masson’s
trichrome stained sections as previously described [14,16].
Infarct size was calculated as the percentage of LV
circumference occupied by infarct scar. Infarct thickness was
calculated using mid-myocardial slides, averaging three equally
spaced measurements along the infarct wall. Cross sections
(4µm thick) were stained with Masson’s trichrome for the
measurement of fibrosis using Bioquant image analysis
software (Nashville,TN).
Apoptosis
To detect apoptosis, TUNEL-staining was carried out as
previously described [10,11]. Hoechst 33258 (10 μM; Sigma)
staining was used to count the total number of nuclei.
Apoptosis was calculated as the percentage of apoptotic
cardiac cell nuclei / total number of nuclei. To identify apoptosis
associated with cardiac myocytes, the sections were
immunostained using α-sarcomeric actin antibodies (1:50, 5C5
clone; Sigma, St. Louis, MO). TUNEL-positive nuclei that were
clearly seen within cardiac myocytes were counted. The
number of apoptotic myocyte nuclei was counted, and index of
apoptosis was calculated as the percentage of apoptotic
myocyte nuclei/total number of nuclei. In isolated cells, the
percentage of TUNEL-positive cells (relative to total myocytes)
was determined by counting ~200 cells in 10 randomly chosen
fields per coverslip for each experiment.
Immunohistochemistry
Sections (4µm thick) were deparrafinized and stained with
anti-α-smooth muscle actin (α-SMA) as described [11]. The
sections were visualized using fluorescent microscopy (Nikon)
and images were acquired using Retiga 1300 color-cooled
camera. Images were quantitatively analyzed using Bioquant
Image analysis software (Nashville, TN).
Western blot analysis
LV lysates were prepared in RIPA buffer as previously
described [17]. Protein lysates (50 μg) were separated by SDS-
PAGE (10%) and transferred to a PVDF membrane (240 mA,
2.5 h). The membranes were incubated with antibodies against
p-p53 (serine-15; Cell Signaling), MMP-9 and MMP-2
(Millipore), TIMP-2 and TIMP-4 (Chemicon), and SOD-2 (Santa
Cruz). Membranes were stripped and probed with GAPDH
(Santa Cruz) as a protein loading control. Band intensities were
quantified using Kodak photodocumentation system (Eastman
Kodak Co.). The data are presented as fold change vs WT-
sham.
In-gel zymography
In gel zymography was performed on 50 μg of LV lysates
from WT-MI and hKO-MI hearts as previously described [18].
Clear and digested regions representing MMP-2 and MMP-9
activity were quantified using a Kodak documentation system.
Cell isolation, culture and treatment
Adult rat ventricular myocytes (ARVMs) were isolated as
previously described [19]. ARVMs were plated in Dulbecco’s
modified Eagle’s medium (DMEM; Mediatech) supplemented
with HEPES (25 mM), BSA (0.2%), creatine (5 mM), L-carnitine
ATM in Myocardial Remodeling Post-MI
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(2 mM), taurine (5 mM) and 0.1% penicillin-streptomycin at a
density of 30–50 cells/mm2 on coverslips precoated with
laminin (1μg/cm2). ARVMs cultured for 24 h were treated with
KU-55933 (KU), a specific inhibitor of ATM [20], for 24 h.
Apoptosis was measured using TUNEL-assay as described
above.
Detection of oxidative stress
To detect oxidative stress, ARVMs were treated with KU (0.1
µM and 1 µM) for 3h. Cells were then stained using total
reactive oxygen species (ROS)/superoxide detection kit (Enzo
Life Sciences) and visualized using fluorescent microscopy.
The number of ROS-positive cells (relative to total myocytes)
was determined by counting ~100 cells in 10 randomly chosen
fields per coverslip for each experiment.
Statistical analyses
Data are represented as mean ± SEM. Data were analyzed
using student’s t test or one-way analysis of variance (ANOVA)
and a post hoc Tukey’s test. Probability (p) values of <0.05
were considered to be significant.
Results
Morphometric studies and mortality
Body weights remained unchanged among the sham and MI
groups. Heart weight (HW) and HW to body weight ratios were
increased in both MI groups (p<0.001 vs sham; n=6-12; Table
1) with no significant difference between the two MI groups.
The mortality rates 7 days post-MI were 35% and 18% in WT
and hKO mice, respectively. Masson’s trichrome staining of the
mid-LV sections is shown in Figure 1A. Infarct size measured
as a percentage of the LV circumference occupied by scar
tissue was not different between the WT-MI and hKO-MI
groups (p=NS, Figure 1B). However, infarct thickness
measured from mid-myocardial sections was significantly
greater in hKO-MI group versus WT-MI (Figure 1C).
Table 1. Morphometric Measurements.
 WT-Sham (n=6) hKO-Sham (n=7) WT-MI (n=10) hKO-MI (n=12) p
BW 24.41 ± 0.96 26.49 ± 1.71 23.89 ± 0.76 23.43 ± 0.61  
HW 125.22 ± 7.74 139.08 ± 12.40 153.93 ± 5.27* 158.50 ± 5.93* <0.001
HW/BW 5.11 ± 0.12 5.25 ± 0.04 6.48 ± 0.33* 6.86 ± 0.43* <0.001
Values are mean ± SEM; *comparison between sham and MI group.
doi: 10.1371/journal.pone.0083513.t001
Figure 1.  Infarct size and thickness.  Masson’s trichrome stained sections from WT and hKO hearts were analyzed for the
measurement of infarct size and thickness. A. Transverse sections of the mid-myocardium from WT and hKO hearts post-MI.
Quantitative analysis of infarct size (B) and thickness (C) as measured from trichrome stained hearts; *p<0.05 vs WT; n=5-7.
doi: 10.1371/journal.pone.0083513.g001
ATM in Myocardial Remodeling Post-MI
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Echocardiographic studies
No significant differences in the echocardiographic
parameters were observed between the two sham groups. M-
mode echocardiography revealed a significant decrease in
percent fractional shortening (%FS) and ejection fraction (EF)
in both MI groups when compared to their respective sham
groups. However, the decrease in %FS and EF was
significantly greater in the WT-MI group when compared to
hKO-MI (#p<0.05 vs WT-MI; Figure 2A & B). MI increased LV
end systolic (LVESD) and diastolic (LVEDD) diameters in both
MI groups. However, the increase in LVEDD and LVESD was
significantly lower in hKO-MI when compared to the WT-MI
group (#p<0.05 vs WT-MI; Figure 2C & D).
Fibrosis and Apoptosis
Quantitative analysis of fibrosis using trichrome stained
sections revealed increased fibrosis in hKO-sham group vs
WT-Sham. MI increased fibrosis in the border and infarct LV
regions of both groups when compared to their respective non-
infarct LV regions. Interestingly, the level of fibrosis was greater
in the border and infarct regions of hKO-MI group when
compared to the WT-MI (Figure 3 A&B).
Analysis of apoptosis using TUNEL-staining assay revealed
increased apoptosis in the hKO-sham vs the WT-sham group.
The number of apoptotic cells and myocytes remained
unchanged in the non-infarct LV regions when compared to the
sham groups (Figure 4 B&C). MI increased the number of
apoptotic cells in the border and infarct LV regions of both
groups when compared to the sham and non-infarct LV regions
(Figure 4 A&B). In the border area, the number of apoptotic
cells as well as myocytes was significantly higher in hKO vs
WT group. In the infarct LV region, the number of apoptotic
cells was significantly lower in hKO vs WT group (Figure 4B),
while the number apoptotic myocytes remained unchanged
between WT and hKO (Figure 4C).
Expression of α-smooth muscle actin (α-SMA)
Expression of α-SMA serves as a marker for the
differentiation of fibroblasts into myofibroblasts [21–23]. MI
increased α-SMA expression in the infarct LV regions of both
groups (Figure 5A). Quantitative immunohistochemical analysis
of heart sections revealed increased α-SMA expression in the
infarct LV region of hKO when compared to the WT group
(Figure 5B).
Expression of matrix metalloproteinases (MMPs) and
tissue inhibitors of MMPs (TIMPs)
Western blot analyses of LV lysates revealed no significant
increase in MMP-2 protein levels in the non-infarct LV regions
of both MI groups when compared to sham. MMP-2 protein
levels were significantly higher in the infarct region of both MI
groups when compared to sham. In the hKO group, the
increase in MMP-2 protein levels was significantly greater in
the infarct region when compared to the non-infarct region
(Figure 6A). MMP-9 protein levels were increased in the non-
infarct region and decreased in the infarct region of the WT
Figure 2.  ATM deficiency improves LV function 7 days post-MI.  MI was performed in WT (n=10) and ATM hKO (n=12) mice.
Indices of cardiac function (percent fractional shortening, %FS; ejection fraction, EF) and structure (LV end diastolic diameter,
LVEDD; LV end systolic diameter, LVESD) were measured using echocardiography 7 days after MI. A. %FS; B. EF; C, LVEDD; D.
LVESD; *p<0.05 vs sham; #p<0.05 vs WT-MI; n=10-12.
doi: 10.1371/journal.pone.0083513.g002
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group when compared to sham. No such changes in MMP-9
protein levels were observed in the hKO group. In the infarct
region, MMP-9 protein levels were significantly greater in the
hKO group when compared to the WT (Figure 6B). Analysis of
MMPs activity using in-gel zymography showed no difference
in MMP-2 activity the infarct LV regions between the two MI
groups (Figure 6C). However, MMP-9 activity in the hKO was
significantly higher in the hKO group when compared to WT
(Figure 6D).
TIMP-2 is suggested to inhibit MMP-2 activity [4], while
TIMP-4 is predominantly expressed in the heart [24] . Western
blot analyses showed no immunostaining for TIMP-2 in the
sham groups. MI increased TIMP-2 protein levels in the non-
infarct and infarct regions of the heart in both groups. However,
TIMP-2 protein levels were significantly greater in the infarct
region when compared to the non-infarct LV region with no
significant difference between the WT and hKO groups (Figure
7A). On the contrary, TIMP-4 protein levels were clearly
present in both the sham groups. MI decreased TIMP-4 protein
levels in the infarct LV region of both groups. TIMP-4 protein
levels were significantly lower in hKO group when compared to
WT (Figure 7B).
Expression and phosphorylation of apoptosis-related
proteins
ATM phosphorylates p53 (serine-15) following DNA damage
[25]. Western blot analyses of LV lysates using anti-p53
antibodies showed no immunostaining for p53 in the sham or
non-infarct LV regions of WT or hKO groups. Phosphorylation
of p53 (serine-15) was only observed in the infarct regions with
a greater increase in the hKO-MI group (Figure 8A).
Deficiency of ATM is suggested to associate with increased
oxidative stress [26]. Intrinsic mitochondrial abnormalities are
also reported in thymocytes lacking ATM [27]. Western blot
analysis of mitochondrial antioxidant protein manganese
superoxide dismutase (SOD-2) demonstrated no change in
SOD-2 protein levels in the sham and non-infarct LV regions of
the heart in both groups. MI significantly decreased SOD-2
protein levels in the infarct LV of both groups. However, the
decrease in SOD-2 protein levels was significantly higher in
hKO group vs WT (Figure 8B).
Oxidative stress and apoptosis in ARVMs
Inhibition of ATM using KU-55933 (KU) is shown to increase
reactive oxygen species (ROS) in cancer cells [28]. To
investigate if inhibition of ATM also increases ROS in
myocytes, ARVMs were treated with KU (0.1 µM and 1 µM) for
Figure 3.  Analysis of fibrosis.  Masson’s trichrome stained sections of the heart were used for quantitative measurement of
fibrosis. A. Masson’s trichrome-stained sections demonstrating fibrosis in WT and hKO mice 7 days post-MI. B. Quantitative
analysis of fibrosis. NINF, non-infarct LV region; INF, infarct; *p<0.05 vs sham; #p<0.05 comparisons between WT and hKO groups;
$p<0.05 vs border; n=6-7.
doi: 10.1371/journal.pone.0083513.g003
ATM in Myocardial Remodeling Post-MI
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3 h. Analysis of ROS-positive ARVMs using fluorescent
microscopy showed increased number of ROS-positive ARVMs
at both concentrations of KU (Figure 9A). To investigate if
inhibition of ATM induces apoptosis, ARVMs were treated with
KU (0.1 µM and 1 µM) for 24 h. Measurement of apoptosis
using TUNEL-assay showed that KU at 0.1 µM and 1 µM
concentrations significantly increases the number of apoptotic
ARVMs (Figure 9B).
Discussion
Previous studies from our lab have shown that lack of ATM
induces structural and functional changes in the heart [10,11].
A major finding of this study is that deficiency of ATM
attenuates LV dysfunction and dilatation 7 days post-MI.
Although infarct size were comparable between the WT and
hKO mice, infarct thickness was greater in the hKO mice.
Deficiency of ATM associated with increased expression of α-
SMA and fibrosis. Cardiac cell apoptosis was lower in the
infarct LV region of ATM deficient mice. However, apoptosis
was significantly higher in the border area of the infarct in ATM
deficient mice. ATM deficiency also associated with changes in
the expression of fibrosis- and apoptosis-related proteins. In
vitro, inhibition of ATM increased the number of ROS-positive
ARVMs and induced apoptosis. The results presented here
suggest that ATM plays a multifaceted role in remodeling
pathways following myocardial infarction.
Systolic dysfunction is characterized by decreased cardiac
contractility and pumping capacity of the heart. In general, MI
results in severe LV dilation and systolic dysfunction [29]. The
data presented here demonstrate that ATM deficient mice
suffer to a lesser degree from impaired systolic function
following MI. The study also provides evidence that deficiency
of ATM affects the infarct scar. We observed that the infarct
size remained unchanged between WT and ATM deficient
mice. However, infarct thickness was greater in the ATM
deficient mice. Fibrosis and expression of α-SMA, a marker of
myofibroblasts, was significantly higher in the ATM deficient
heart after MI. Our findings suggest that myofibroblasts, a
major cell type involved in the deposition of fibrosis, may
escape the apoptotic death during the granulation phase and
contribute to the increase in infarct wall thickness in the ATM
deficient mice. This may in turn decrease LV dilation and
dysfunction. Of note, cardiac cell apoptosis in the infarct LV
region of ATM deficient mice was lower when compared to that
in the WT. Increased infarct thickness with reduced apoptosis
in granulation tissue cells is previously described in
Angiotensin II type 1A receptor KO (AT1AKO) 7 days post-MI
[30]. Expression of soluble transforming growth factor-β (TGF-
β) type II receptor, a competitive inhibitor of TGF-β, led to a
greater infarct thickness and smaller LV circumference [31].
Therefore, it is conceivable that ATM signaling may involve
Angiotensin II and/or TGF-β axis for its effect on infarct
thickness, LV circumference and apoptosis. Further
Figure 4.  Analysis of apoptosis.  A. TUNEL-stained images from the border regions of WT and hKO hearts post-MI. B.
Quantitative analysis of cardiac cell apoptosis in the non-infarcted (NINF), border and infarct (INF) regions of WT and hKO mice 7
days post-MI. C. Quantitative analysis of myocyte apoptosis in the NINF, border and INF regions of WT and hKO mice 7 days post-
MI. *p<0.05 vs sham; #p<0.05 comparisons between WT and hKO groups; $p<0.05 vs border; n=4.
doi: 10.1371/journal.pone.0083513.g004
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investigations are warranted to clarify the role of these
molecules in ATM signaling.
Cardiac structure consists of various cell types whose
function is to promote contractility of the heart. Following injury,
macrophages and other immune cells initiate a healing
process. Once the damaged cells have been removed,
activation of myofibroblasts helps promote scar tissue
formation. This response is suggested to be associated with
increases in α-SMA [21,32]. We observed greater increase in
α-SMA expression in the infarct region of ATM deficient mice.
Increased α-SMA may help explain the presence of increased
fibrosis in the infarct region of ATM deficient mice.
Cardiac cell apoptosis increases in the infarct and border
areas and to a smaller extent in the non-infarcted areas of the
heart after MI [6,33]. Early activation of apoptosis is a
necessary step in remodeling as it allows room for entry of
immune repair cells following injury [1,34,35]. The infarct region
is a predictor of post-MI prognosis as it can relate to infarct
expansion. ATM deficient mice exhibited a greater increase in
apoptosis in the border region. This may lead to a greater
infarct expansion and worse prognosis late post-MI [1,3,36].
Likewise, increased granulation tissue cell apoptosis in WT-MI
hearts may reflect timely removal of unhealthy cells, thereby
enhancing the repair process.
The matrix metalloproteinases (MMPs) are endopeptidases
that are present within the myocardium. Changes in MMP
abundance is shown to be associated with changes in
extracellular matrix deposition (ECM) and LV remodeling post-
MI, including increased LV dilation and cardiac rupture [37–41].
The ECM is a critical component in the restructuring of the
heart after MI. Using promoter reporter constructs, Mukherjee
et. al. showed that MMP-2 promoter activation peaks in the MI
region 7 days post-MI, while MMP-9 promoter activation was
highest in the border region at 7 and 14 days post-MI [42].
Consistent with these findings, we observed increased MMP-2
protein levels in the MI regions of both groups when compared
to their respective sham groups. No difference in MMP-2
protein levels and activity in the infarct LV region suggest that
increased fibrosis in hKO mice occurs via MMP-2-independent
mechanism. MMP-9 protein levels were significantly higher in
the non-infarct LV region of WT group when compared to
sham. However, we observed decreased MMP-9 protein levels
in the infarct LV region of WT group. No such changes in
MMP-9 protein levels were observed in the hKO group. MMP-9
activity was higher in the infarct LV region of hKO when
compared to WT. Higher MMP-9 protein levels and activity
suggest involvement of MMP-9 in ECM deposition and LV
remodeling during ATM deficiency. The decreased MMP-9
protein levels observed in this study in the WT infarct region
may reflect localization and/or timing of the remodeling events
[43].. Tao et al. has shown that MMP-9 activity increases as
early as 1 day post-MI and reaches a maximum by 2 days,
Figure 5.  Expression of α-smooth muscle actin (α-SMA).  A. α-SMA-stained images from the infarct LV regions of WT and hKO
hearts post-MI. B. Quantitative immunohistological analysis of α-SMA expression in the infarct (INF) region of WT and hKO mice 7
days post-MI. #p<0.05 vs WT-INF; n=4.
doi: 10.1371/journal.pone.0083513.g005
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then gradually decreases. MMP-2 activity starts to increase 4
days post-MI, reaching a maximum by 7 days [41].
TIMP’s are traditionally believed to function solely as
inhibitors of active MMPs [4]. TIMP-2 is suggested to have
maximum affinity for MMP-2 [44]. In the heart, MMP-9 and
TIMP-4 are suggested to play a key in the myocardial
remodeling. In cardiac myocytes, the effects of MMP-9 on
voltage-induced contraction can be reversed by TIMP-4 [45].
We observed increased TIMP-2 expression in the infarct region
of both groups to a similar extent. However, TIMP-4 protein
Figure 6.  Expression and activity of MMPs.  A & B. Total LV lysates (50 µg), prepared from sham and non-infarct (NINF) and
infarct (INF) LV regions, were analyzed by western blot using anti-MMP-2 (A) and anti-MMP-9 (B) antibodies. The upper panels
show autoradiograms indicating immunostaining for MMP-2, MMP-9, and GAPDH. The lower panels exhibit quantitative analyses of
MMP-2, MMP-9 normalized to GAPDH. *p<0.05 vs sham; #p<0.05 vs NINF; $p<0.05 vs WT-INF; n=7. C&D. Total LV lysates (50 µg),
prepared from the infarct LV regions were analyzed by in-gel zymography. C. MMP-2 activity. D. MMP-9 activity. *p<0.05 vs WT-MI;
n=3.
doi: 10.1371/journal.pone.0083513.g006
Figure 7.  Expression of TIMPs.  Total LV lysates (50 µg), prepared from sham and non-infarct (NINF) and infarct (INF) LV
regions, were analyzed by western blot using anti-TIMP-2 (A) and anti-TIMP-4 (B) antibodies. The upper panels show
autoradiograms indicating immunostaining for TIMP-2, TIMP-4, and GAPDH. The lower panels exhibit quantitative analyses of
TIMP-2, TIMP-4 normalized to GAPDH. *p<0.05 vs sham; #p<0.05 vs NINF; $p<0.05 vs WT-INF; n=7.
doi: 10.1371/journal.pone.0083513.g007
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levels were significantly lower in the ATM deficient mice. ATM
deficient mice also exhibited increased MMP-9 protein levels
and activity in the infarct region when compared to their WT
counterparts. Increased MMP-9 activity is expected to correlate
with decreased fibrosis in ATM deficient mice. However, we
observed increased fibrosis in the infarct and remote regions of
ATM deficient mice. Recent evidence suggests additional roles
for TIMPs independent of their function as MMP inhibitors [36].
Therefore, it is plausible that changes in TIMP protein levels
observed in the infarct region of WT and ATM deficient mice
could function in the remodeling processes of the heart
independent of MMP-2 and -9.
ATM deficiency results in impaired repair of double-stranded
DNA breaks and increased oxidative stress [26,46]. Deceased
SOD levels impair the cell’s response to handle reactive
oxygen species following myocardial injury [47,48]. ATM is also
known to phosphorylate p53 on serine-15 resulting in its
stabilization. Stabilization of p53 increases its transcriptional
activity, leading to increased apoptosis [49]. Here we observed
greater increase in phosphorylation of p53 in the infarct region
of ATM deficient hearts. On the other hand, SOD-2 protein
levels were lower in ATM deficient hearts, suggesting
enhanced oxidative stress during ATM deficiency. Enhanced
oxidative stress and apoptosis was also observed in ARVMs
during inhibition of ATM using KU-55933. It can be argued that
increased p53 phosphorylation and oxidative stress should
increase apoptosis in the infarct region of ATM deficient mice.
We did observe increased apoptosis in the border area of ATM
Figure 8.  Expression and phosphorylation of apoptosis related proteins.  A. Total LV lysates were analyzed by western blot
using phospho-specific (serine-15) p53 or total p53 antibodies. Protein loading in each lane is indicated by GAPDH immunostaining.
$p<0.05 vs WT-INF; n=7. B. Total LV lysates were analyzed by western blot using anti-SOD-2 antibodies. Protein loading in each
lane is indicated by GAPDH. *p<0.05 vs sham; $p<0.05 vs NINF; #p<0.05 vs WT-INF; n=7.
doi: 10.1371/journal.pone.0083513.g008
Figure 9.  Inhibition of ATM increases the number of ROS-positive ARVMs and induces apoptosis.  ARVMs were treated with
KU-55933 (KU) for 3 h (A) or 24 h (B). A. Cells were stained using ROS-detection kit and ROS-positive cells were counted using
fluorescent microscopy. *p<0.05 vs control (CTL); n=3. B. TUNEL-assay was used to count the number of apoptotic ARVMs.
*p<0.05 vs CTL; n=3.
doi: 10.1371/journal.pone.0083513.g009
ATM in Myocardial Remodeling Post-MI
PLOS ONE | www.plosone.org 9 December 2013 | Volume 8 | Issue 12 | e83513
deficient mice. However, apoptosis was lower in the infarct
region of ATM deficient mice. Inhibition of ATM and ATR failed
to prevent H2O2-induced phosphorylation of p53 in neonatal
cardiac myocytes [50]. In addition, graded increases in the
level of oxidative stress induce a graded phenotype shift in
cardiac myocytes, from hypertrophy at low levels of oxidative
stress, to apoptosis at high levels of oxidative stress [51].
Therefore, it is conceivable that p53 phosphorylation during
ATM deficiency involves signaling pathways independent of
ATM, and increased oxidative stress during ATM deficiency
promotes cell growth in the infarct LV region at this time point.
Conclusion and study limitations
The data presented here provide evidence that ATM has the
potential to modulate infarct tissue dynamics. It alters the
infarct structure by affecting apoptosis, fibrosis, and expression
of α-SMA. It should be emphasized that our data on
investigating the role of ATM in myocardial remodeling post-MI
are obtained 7 days post-MI. Changes in the size and
thickness of infarct scar can eventually affect infarct expansion
and contribute to the diastolic dysfunction. Therefore, it is
possible that increased fibrosis (stiffness) and apoptosis (in the
border area) in ATM deficient mice may associate with earlier
diastolic dysfunction if the study time points are extended
beyond 7 days post-MI.
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